Portfolio

NSIA LUTH Cancer Centre (NLCC)

Project Details

Sector

Healthcare

Participants

NHDIC

Commencement Date

31 May 2019

States
Lagos

NLCC is an out-patient cancer centre, established as a joint venture between NHDIC and LUTH. Services offered by NLCC include consultation, radiotherapy, chemotherapy and pharmacy.
The equipment mix at NLCC includes:

  • 2 Vital Beam Linear Accelerators;
  • 1 Halcyon machine;
  • 1 GammaMed Brachytherapy machine;
  • 1 CT Simmulator;
  • 1 C-arm Machine; and
  • 1 Ultrasound machine
  • Contribution to the reduction in mortality rates and improvement of outcomes for cancer patients.
  • Provision of cancer treatment services to 5,505 as Q2 2022
  • Contribution to employment through the direct employment of 80 persons.
  • Establishment of a training centre to build capacity in radiation treatment delivery for current and future clinical professionals in Nigeria.
  • Reduction in outbound medical tourism and subsequent conservation of foreign exchange
  • Provision of additional source of income to LUTH to enable the institution to allocate much needed funds to other services and improve quality of healthcare delivery.

PARTNERS

How the fund is invested

US$12.5million

Project Cost / Size:

100% owned by NHDIC

NSIA’s interest:

100% equity

Funding structure

15

Investment areas

Related Projects

11th September 2013
Lagos
Motorways
14th August 2018
Delta
Motorways
Q4 2021
Lagos
Technology
25th April 2018
Kano
Motorways
December 2016
Nationwide
Agriculture
Q4 2023
Lagos
Real Estate